Innovative Capital Expenditures vs Net Borrowings Analysis

002173 Stock

8.93 0.55 6.56%

Innovative Medical financial indicator trend analysis is infinitely more than just investigating Innovative Medical recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Innovative Medical is a good investment. Please check the relationship between Innovative Medical Capital Expenditures and its Net Borrowings accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Innovative Medical Management. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Capital Expenditures vs Net Borrowings

Capital Expenditures vs Net Borrowings Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Innovative Medical Capital Expenditures account and Net Borrowings. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Innovative Medical's Capital Expenditures and Net Borrowings is -0.01. Overlapping area represents the amount of variation of Capital Expenditures that can explain the historical movement of Net Borrowings in the same time period over historical financial statements of Innovative Medical Management, assuming nothing else is changed. The correlation between historical values of Innovative Medical's Capital Expenditures and Net Borrowings is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Expenditures of Innovative Medical Management are associated (or correlated) with its Net Borrowings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Borrowings has no effect on the direction of Capital Expenditures i.e., Innovative Medical's Capital Expenditures and Net Borrowings go up and down completely randomly.

Correlation Coefficient

-0.01

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Capital Expenditures

Capital Expenditures are funds used by Innovative Medical to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Innovative Medical operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Net Borrowings

The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.

Most indicators from Innovative Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Innovative Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Innovative Medical Management. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Selling General Administrative is expected to grow to about 40.6 M, whereas Discontinued Operations is forecasted to decline to (9.9 M).

	2021	2022	2023	2024 (projected)
Other Operating Expenses	3.4M	3.7M	3.3M	4.8M
Gross Profit	46.2M	30.6M	92.2M	120.8M

Other Operating Expenses Gross Profit

Innovative Medical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Accounts Payable	Cash	Net Receivables	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Other Assets	Long Term Debt	Other Liab	Treasury Stock	Net Tangible Assets	Other Stockholder Equity	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Total Current Assets	Short Term Debt	Non Current Assets Total
Total Assets		0.04	0.56	0.99	0.0	0.43	0.81	0.72	-0.07	0.39	0.75	0.8	0.76	0.65	0.85	0.09	0.51	-0.02	0.88	0.84	0.36	0.83	0.83	0.83	0.75	-0.02
Other Current Liab	0.04		0.44	-0.03	0.35	-0.36	-0.24	-0.01	0.48	-0.03	0.42	-0.18	-0.22	-0.32	-0.32	0.06	0.05	-0.51	-0.23	-0.23	-0.51	-0.24	-0.04	0.15	-0.24	0.28
Total Current Liabilities	0.56	0.44		0.46	0.5	-0.2	0.34	0.47	0.72	0.06	0.94	0.2	0.21	-0.04	0.28	0.25	-0.15	-0.17	0.23	0.16	-0.23	0.15	0.6	0.73	0.0	0.4
Total Stockholder Equity	0.99	-0.03	0.46		-0.06	0.49	0.82	0.71	-0.18	0.41	0.67	0.83	0.78	0.7	0.87	0.04	0.56	0.01	0.92	0.88	0.42	0.87	0.82	0.79	0.8	-0.08
Retained Earnings	0.0	0.35	0.5	-0.06		-0.89	-0.15	0.42	0.77	0.32	0.35	-0.55	-0.59	-0.73	-0.29	0.6	-0.72	-0.53	-0.42	-0.52	-0.82	-0.53	0.4	0.45	-0.62	0.98
Accounts Payable	0.43	-0.36	-0.2	0.49	-0.89		0.48	0.0	-0.73	-0.06	0.01	0.85	0.89	0.95	0.67	-0.49	0.82	0.51	0.78	0.82	0.93	0.83	0.04	-0.04	0.88	-0.88
Cash	0.81	-0.24	0.34	0.82	-0.15	0.48		0.45	-0.12	0.12	0.55	0.74	0.68	0.61	0.8	0.07	0.46	0.09	0.79	0.81	0.37	0.81	0.56	0.64	0.67	-0.18
Net Receivables	0.72	-0.01	0.47	0.71	0.42	0.0	0.45		0.08	0.75	0.56	0.35	0.38	0.27	0.65	0.44	0.0	-0.11	0.52	0.38	0.06	0.37	0.84	0.72	0.34	0.44
Inventory	-0.07	0.48	0.72	-0.18	0.77	-0.73	-0.12	0.08		-0.2	0.54	-0.49	-0.46	-0.68	-0.37	0.49	-0.62	-0.36	-0.46	-0.49	-0.74	-0.5	0.13	0.32	-0.63	0.67
Other Current Assets	0.39	-0.03	0.06	0.41	0.32	-0.06	0.12	0.75	-0.2		0.13	0.15	0.15	0.14	0.44	0.21	-0.06	-0.14	0.27	0.17	0.1	0.16	0.63	0.29	0.21	0.44
Total Liab	0.75	0.42	0.94	0.67	0.35	0.01	0.55	0.56	0.54	0.13		0.42	0.43	0.19	0.49	0.27	0.12	-0.18	0.46	0.41	-0.06	0.4	0.67	0.81	0.25	0.26
Intangible Assets	0.8	-0.18	0.2	0.83	-0.55	0.85	0.74	0.35	-0.49	0.15	0.42		0.95	0.94	0.88	-0.4	0.79	0.32	0.97	0.97	0.77	0.97	0.47	0.44	0.94	-0.56
Common Stock	0.76	-0.22	0.21	0.78	-0.59	0.89	0.68	0.38	-0.46	0.15	0.43	0.95		0.96	0.88	-0.24	0.74	0.44	0.94	0.93	0.83	0.94	0.42	0.35	0.92	-0.61
Property Plant Equipment	0.65	-0.32	-0.04	0.7	-0.73	0.95	0.61	0.27	-0.68	0.14	0.19	0.94	0.96		0.83	-0.36	0.82	0.45	0.92	0.93	0.9	0.93	0.3	0.21	0.96	-0.72
Other Assets	0.85	-0.32	0.28	0.87	-0.29	0.67	0.8	0.65	-0.37	0.44	0.49	0.88	0.88	0.83		-0.08	0.54	0.3	0.92	0.88	0.7	0.88	0.67	0.54	0.83	-0.26
Long Term Debt	0.09	0.06	0.25	0.04	0.6	-0.49	0.07	0.44	0.49	0.21	0.27	-0.4	-0.24	-0.36	-0.08		-0.4	-0.31	-0.2	-0.24	-0.46	-0.24	0.25	0.3	-0.34	0.58
Other Liab	0.51	0.05	-0.15	0.56	-0.72	0.82	0.46	0.0	-0.62	-0.06	0.12	0.79	0.74	0.82	0.54	-0.4		0.16	0.71	0.8	0.67	0.8	0.04	0.08	0.85	-0.73
Treasury Stock	-0.02	-0.51	-0.17	0.01	-0.53	0.51	0.09	-0.11	-0.36	-0.14	-0.18	0.32	0.44	0.45	0.3	-0.31	0.16		0.29	0.31	0.61	0.33	-0.07	-0.25	0.34	-0.5
Net Tangible Assets	0.88	-0.23	0.23	0.92	-0.42	0.78	0.79	0.52	-0.46	0.27	0.46	0.97	0.94	0.92	0.92	-0.2	0.71	0.29		0.97	0.71	0.97	0.62	0.57	0.94	-0.43
Other Stockholder Equity	0.84	-0.23	0.16	0.88	-0.52	0.82	0.81	0.38	-0.49	0.17	0.41	0.97	0.93	0.93	0.88	-0.24	0.8	0.31	0.97		0.74	1.0	0.51	0.47	0.96	-0.52
Deferred Long Term Liab	0.36	-0.51	-0.23	0.42	-0.82	0.93	0.37	0.06	-0.74	0.1	-0.06	0.77	0.83	0.9	0.7	-0.46	0.67	0.61	0.71	0.74		0.75	0.11	-0.11	0.81	-0.77
Long Term Investments	0.83	-0.24	0.15	0.87	-0.53	0.83	0.81	0.37	-0.5	0.16	0.4	0.97	0.94	0.93	0.88	-0.24	0.8	0.33	0.97	1.0	0.75		0.51	0.46	0.96	-0.53
Short Long Term Debt	0.83	-0.04	0.6	0.82	0.4	0.04	0.56	0.84	0.13	0.63	0.67	0.47	0.42	0.3	0.67	0.25	0.04	-0.07	0.62	0.51	0.11	0.51		0.87	0.41	0.41
Total Current Assets	0.83	0.15	0.73	0.79	0.45	-0.04	0.64	0.72	0.32	0.29	0.81	0.44	0.35	0.21	0.54	0.3	0.08	-0.25	0.57	0.47	-0.11	0.46	0.87		0.3	0.39
Short Term Debt	0.75	-0.24	0.0	0.8	-0.62	0.88	0.67	0.34	-0.63	0.21	0.25	0.94	0.92	0.96	0.83	-0.34	0.85	0.34	0.94	0.96	0.81	0.96	0.41	0.3		-0.61
Non Current Assets Total	-0.02	0.28	0.4	-0.08	0.98	-0.88	-0.18	0.44	0.67	0.44	0.26	-0.56	-0.61	-0.72	-0.26	0.58	-0.73	-0.5	-0.43	-0.52	-0.77	-0.53	0.41	0.39	-0.61

Click cells to compare fundamentals

Innovative Medical Account Relationship Matchups

Innovative Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	3.0B	2.7B	2.6B	2.3B	2.3B	1.9B
Other Current Liab	30.8M	113.8M	77.2M	6K	47.7K	45.3K
Total Current Liabilities	315.8M	358.4M	346.0M	322.4M	325.4M	442.5M
Total Stockholder Equity	2.5B	2.1B	2.0B	1.9B	1.9B	1.4B
Retained Earnings	(739.3M)	(1.1B)	(1.2B)	(1.3B)	(1.3B)	(1.2B)
Accounts Payable	166.6M	180.5M	183.4M	210.1M	208.1M	218.5M
Cash	879.3M	346.3M	225.7M	658.5M	563.1M	314.9M
Net Receivables	213.9M	72.9M	89.4M	51.6M	102.8M	136.7M
Inventory	53.5M	34.5M	43.0M	49.3M	41.8M	39.7M
Other Current Assets	19.5M	20.2M	7.8M	3.0M	1.1M	1.1M
Total Liab	498.1M	533.1M	565.3M	434.4M	410.4M	525.7M
Intangible Assets	132.0M	128.7M	125.2M	121.8M	129.6M	136.0M
Property Plant Equipment	1.4B	1.4B	1.4B	1.4B	1.6B	1.7B
Other Assets	121.5M	89.0M	38.5M	73.5M	84.5M	88.8M
Long Term Debt	42.4M	66.5M	39M	9M	8.1M	7.7M
Other Liab	120.9M	165.7M	185.4M	90.5M	104.1M	54.8M
Net Tangible Assets	2.5B	2.2B	2.0B	1.9B	2.1B	2.2B
Deferred Long Term Liab	36.2M	28.9M	22.6M	52.6M	60.4M	63.5M
Short Long Term Debt	215M	1.7M	3M	23.1M	30.2M	28.7M
Total Current Assets	1.2B	1.1B	940.0M	771.6M	733.1M	1.1B
Non Current Assets Total	1.7B	1.6B	1.6B	1.6B	1.5B	1.5B
Non Currrent Assets Other	29.6M	7.5M	6.7M	1.6M	1.8M	1.7M
Good Will	1.0B	127.0M	0.0	986.7K	888.1K	843.7K
Non Current Liabilities Total	182.3M	174.7M	219.3M	112.0M	85.0M	129.2M
Non Current Liabilities Other	70.1M	113.4M	130.4M	39.2M	16.0M	15.2M
Short Term Investments	61.4M	593.5M	574.0M	20.1M	18.1M	17.2M
Net Invested Capital	2.5B	2.2B	2.0B	1.9B	1.9B	2.1B
Net Working Capital	911.9M	761.6M	594.1M	449.3M	407.6M	669.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Other Information on Investing in Innovative Stock

Balance Sheet is a snapshot of the financial position of Innovative Medical at a specified time, usually calculated after every quarter, six months, or one year. Innovative Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Innovative Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Innovative currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Innovative Capital Expenditures vs Net Borrowings Analysis

Capital Expenditures vs Net Borrowings

Capital Expenditures vs Net Borrowings Correlation Analysis

Correlation Coefficient

Capital Expenditures

Net Borrowings

Innovative Medical fundamental ratios Correlations

Innovative Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Innovative Medical fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Innovative Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Long Term Investments	+ 1.0	Other Stockholder Equity
Total Stockholder Equity	+ 0.99	Total Assets
Non Current Assets Total	+ 0.98	Retained Earnings
Net Tangible Assets	+ 0.97	Intangible Assets
Other Stockholder Equity	+ 0.97	Intangible Assets
Long Term Investments	+ 0.97	Intangible Assets

Accounts Payable	- 0.89	Retained Earnings
Non Current Assets Total	- 0.88	Accounts Payable
Deferred Long Term Liab	- 0.82	Retained Earnings
Non Current Assets Total	- 0.77	Deferred Long Term Liab
Deferred Long Term Liab	- 0.74	Inventory
Non Current Assets Total	- 0.73	Other Liab